DNIB Unwind Inc Stock OTC Bulletin Board
Equities
BINDQ
US05548N1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | - | 16-07-23 |
1st Jan change | Capi. | |
---|---|---|
-2.94% | 102B | |
+2.32% | 96.84B | |
-0.44% | 21.48B | |
-18.49% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.81% | 13.78B | |
+0.30% | 13.4B | |
+20.65% | 11.06B |
- Stock Market
- Equities
- BINDQ Stock
- BINDQ Stock